all true, however I think the trials are not really all that delayed. FDA approval takes time and I don't think anyone in the history of drug approvals would say it is possible to have delays and a few pot holes along the way. Look at any drug from any size company and there is a history of difficult times getting through FDA trials and approval. To think that this is why CYDY is valued so low does not really explain things. Even the cost of these trials is quite low on the grand scheme, It looks crazy expensive considering the size of CYDY but again, FDA trials are never cheap. My point is that for most every reason we can come up with as to why CYDY is locked in this price basement there is an example of other companies that are not with less promising/compelling products. We can't blame the short sellers, the OTC, the FDA and certainly not Pro140. Many other OTC companies navigate these things with far better outcomes. The only thing my attention is on is what mgmt. could have done or should be doing to fix this problem.
There is a very strong chance that what thy are doing is 100% the right thing, by raising cash only as needed and with a very defined terms based on the market at that time we might be able to hold out for the blockbuster deal of a lifetime. Mgmt is trying to keep us informed more frequently but they must also be very careful about what they say. We really do not need a shareholder lawsuit getting the FDA pissed off or some SEC issue.
Nader's attitude leaves me with the feeling that even if things are a disaster - he would be somewhat oblivious to it. this is what scares me - he might really not be able to see the risk of screwing this up and not be able to see just how crazy this valuation is relative to pro140's potential. He likely thinks any negative opinion on his mgmt. is to be dis-regarded and that investors do not get his vision.
News 
Market Data 
Discover 
AI
